Antex Biologics2003; Antex files Chlamydia investigational new drug application with FDA. STD vaccine clinical trial Press release, 3 February 2003 http://www.antexbiologics.com/news_pr/pr030203.phtm
Buzoni-GatelD,
GuilloteauL,
BernardF,
BernardS,
ChardesT,
RoccaA.1992; Protection against Chlamydia psittaci in mice conferred by Lyt-2+ T cells. Immunology 77:284–288
de la MazaM. A,
de la MazaL. M.1995; A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. Vaccine 13:119–127[CrossRef]
FlingS. P,
SutherlandR. A,
SteeleL. N,
HessB,
D'OrazioS. E. F,
MaisonneuveJ,
LampeM. F,
ProbstP,
StarnbachM. N.2001; CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis . Proc Natl Acad Sci U S A 98:1160–1165[CrossRef]
GentschevI,
DietrichG,
SprengS,
PilgrimS,
StritzkerJ,
Kolb-MaurerA,
GoebelW.2002; Delivery of protein antigens and DNA by attenuated intracellular bacteria. Int J Med Microbiol 291:577–582
HayesL. J,
ConlanJ. W,
EversonJ. S,
WardM. E,
ClarkeI. N.1991; Chlamydia trachomatis major outer membrane protein epitopes expressed as fusions with LamB in an attenuated aroA strain of Salmonella typhimurium ; their application as potential immunogens. J Gen Microbiol 137:1557–1564[CrossRef]
HerringA. J,
JonesG. E,
DunbarS. M,
NettletonP. F,
FitzgeraldT. A,
AndersonI. E,
ChapmanS. N,
WilsonT. M. A.1998; Recombinant vaccines against Chlamydia psittaci –an overview of results using bacterial expression and a new approach using a plant virus ‘overcoat’ system. In Proceedings of the Ninth International Symposium on Human Chlamydial Infection pp 434–437 Edited by
StephensR. S.,
ByrneG. I. ,
ChristiansenG.7 others
San Francisco: International Chlamydia Symposium;
HsiaR. C,
PannekoekY,
IngerowskiE,
BavoilP. M.1997; Type III secretion genes identify a putative virulence locus of Chlamydia . Mol Microbiol 25:351–359[CrossRef]
IgietsemeJ. U.2002; Functional immunobiology of Chlamydia : vaccine perspective. In Proceedings of the Tenth International Symposium on Human Chlamydial Infections pp 223–232 Edited by
SchachterJ.,
ChristiansenG.,
ClarkeI. N.11 others
San Francisco: International Chlamydia Symposium;
LampeM. F,
BallweberL. M,
StammW. E.1998a; Cloning and sequence analysis of a putative cytolysin from Chlamydia trachomatis . In Proceedings of the Ninth International Symposium on Human Chlamydial Infection pp 555–558 Edited by
StephensR. S.,
ByrneG.,
ChristiansenI. G.7 others
San Francisco: International Chlamydia Symposium;
LampeM. F,
WilsonC. B,
BevanM. J,
StarnbachM. N.1998b; Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection. Infect Immun 66:5457–5461
LongbottomD,
FindlayJ,
VretouE,
DunbarS. M.1998a; Immunoelectron microscopic localisation of the OMP90 family on the outer membrane surface of Chlamydia psittaci . FEMS Microbiol Lett 164:111–117[CrossRef]
LongbottomD,
RussellM,
DunbarS. M,
JonesG. E,
HerringA. J.1998b; Molecular cloning and characterization of the genes coding for the highly immunogenic cluster of 90-kilodalton envelope proteins from the Chlamydia psittaci subtype that causes abortion in sheep. Infect Immun 66:1317–1324
LuH,
ZhongG. M.1999; Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection. Infect Immun 67:1763–1769
MooreT,
AnanabaG. A,
BolierJ,
BowersS,
BelayT,
EkoF. O,
IgietsemeJ. U.2002; Fc receptor regulation of protective immunity against Chlamydia trachomatis . Immunology 105:213–221[CrossRef]
MurdinA. D,
SuH,
ManningD. S,
KleinM. H,
ParnellM. J,
CaldwellH. D.1993; A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic. Infect Immun 61:4406–4414
PalS,
BarnhartK. M,
WeiQ,
AbaiA. M,
PetersonE. M,
de la MazaL. M.1999; Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge. Vaccine 17:459–465[CrossRef]
RankR. G.1999; Models of immunity. In Chlamydia: Intracellular BiologyPathogenesis and Immunity pp 239–295 Edited by
StephensR. S.
Washington, DC: American Society for Microbiology;
RankR. G,
WhiteH. J,
BarronA. L.1979; Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun 26:573–579
SaikkuP.1998; Chlamydia pneumoniae –clinical spectrum. In Proceedings of the Ninth International Symposium on Human Chlamydial Infection pp 145–154 Edited by
StephensR. S.,
ByrneG. I.,
ChristiansenG.
, 7 others. San Francisco: International Chlamydia Symposium;
ShawJ,
GrundV,
DurlingL,
CraneD,
CaldwellH. D.2002; Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4+ type 2 rather than type 1 immune response that is not protective. Infect Immun 70:1097–1105[CrossRef]
StephensR. S,
KalmanS,
LammelC.9 other authors1998; Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis . Science 282:754–759[CrossRef]
StorzJ.1988; Overview of animal diseases induced by chlamydial infections. In Microbiology of Chlamydia pp 167–192 Edited by
BarronA. L.
Boca Raton, FL: CRC Press;
SuH,
MesserR,
WhitmireW,
FischerE,
PortisJ. C,
CaldwellH. D.1998; Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable chlamydiae. J Exp Med 188:809–818[CrossRef]
TurnerM. S,
GiffardP. M.1999; Expression of Chlamydia psittaci - and human immunodeficiency virus-derived antigens on the cell surface of Lactobacillus fermentum BR11 as fusions to BspA. Infect Immun 67:5486–5489
VanrompayD,
CoxE,
VandenbusscheF,
VolckaertG,
GoddeerisB.1999; Protection of turkeys against Chlamydia psittaci challenge by gene gun-based DNA immunizations. Vaccine 17:2628–2635[CrossRef]
WardM. E.1999; Mechanisms of disease. In Chlamydia: Intracellular BiologyPathogenesis and Immunity pp 171–210 Edited by
StephensR. S.
Washington, DC: American Society for Microbiology;
ZhangD,
YangX,
BerryJ,
ShenC,
McClartyG,
BrunhamR. C.1997; DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. J Infect Dis 176:1035–1040[CrossRef]